Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 29, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents and restricted cash	$ 21,880	$ 24,606
Accounts receivable, net of allowances for credit losses of $30 and $34, as of December 29, 2024 and December 31, 2023, respectively	2,436	1,625
Contract assets	2,682	3,609
Note receivable	0	1,200
Inventories	940	2,029
Prepaid expenses and other current assets	1,666	1,561
Total current assets	29,604	34,630
Property and equipment, net	15,699	8,948
Capitalized internal-use software, net	2,451	2,069
Right of use assets, net	758	981
Intangible assets, net	808	537
Non-marketable equity investment	300	300
Goodwill	185	185
Inventories, non-current	718	0
Note receivable, non-current	1,292	0
Other assets	118	142
TOTAL ASSETS	51,933	47,792
Current liabilities:
Revolving line of credit	18,000	20,000
Trade payables	3,120	4,657
Accrued liabilities	1,611	2,673
Deferred revenue	454	1,052
Notes payable, current	1,928	946
Lease liabilities, current	284	302
Total current liabilities	25,397	29,630
Long-term liabilities:
Lease liabilities, non-current	447	681
Notes payable, non-current	1,202	461
Other long-term liabilities	0	125
Total liabilities	27,046	30,897
Commitments and Contingencies (Note 15)
Stockholders' equity:
Preferred stock, $0.001 par value; 10,000 shares authorized; no shares issued or outstanding	0	0
Common stock, $0.001 par value; 200,000 shares authorized; 15,336 and 14,118 shares issued and outstanding as of December 29, 2024 and December 31, 2023, respectively	15	14
Additional paid-in capital	334,268	322,436
Accumulated deficit	(309,396)	(305,555)
Total stockholders' equity	24,887	16,895
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 51,933	$ 47,792